Details
Description
This poster describes a project which aimed to construct targeted outcome trees based on regulatory Designated Medical Event (DME) lists and compare their performance to routinely used untargeted trees by reanalyzing a prior signal identification analysis of erenumab in the U.S. Sentinel System. It was presented at the 2026 ISPE Annual Meeting.
Additional Information
Contributors
Presenter(s)
Yinchu Cheng